This study sought to assess the @-year outcomes of the population included in the EXAMINATION ( Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction ) trial beyond the @-year prescription period of dual antiplatelet therapy .